Tumor necrosis factor-α-accelerated degradation of type I collagen in human skin is associated with elevated matrix metalloproteinase (MMP)-1 and MMP-3 ex vivo  by Ågren, Magnus S. et al.
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Tumor  necrosis  factor  (TNF)-  induces  matrix  metalloproteinases  (MMPs)  that  may  disrupt  skin  integrity.
We have investigated  the  effects  and  mechanisms  of  exogenous  TNF-  on collagen  degradation  by  incu-
bating  human  skin  explants  in  deﬁned  serum-free  media  with  or without  TNF-  (10  ng/ml)  in  the  absence
or  presence  of  the nonselective  MMP  inhibitor  GM6001  for 8 days.  The  basal  culture  conditions  pro-
moted  type I collagen  catabolism  that  was  accelerated  by  TNF-  (p  <  0.005)  and  accomplished  by  MMPs
(p  <  0.005).  Levels  of the  collagenases  MMP-8  and  MMP-13  were  insigniﬁcant  and  neither  MMP-2  nor
MMP-14  were  associated  with  increased  collagen  degradation.  TNF-  increased  secretion  of  MMP-1
(p  <  0.01)  but  had  no  impact  on MMP-1  quantities  in the tissue.  Immunohistochemical  analysis  conﬁrmed
similar  tissue  MMP-1  expression  with  or without  TNF-  with  epidermis  being  the  major  source  of MMP-1.
Increased  tissue-derived  collagenolytic  activity  with  TNF-  exposure  was  blocked  by  neutralizing  MMP-1
monoclonal  antibody  and was not  due  to down-regulation  of  tissue  inhibitor  of  metalloproteinase-1.  TNF-
 increased  production  (p <  0.01),  tissue  levels  (p  <  0.005)  and  catalytic  activity  of  the  endogenous  MMP-1
activator  MMP-3.  Type  I collagen  degradation  correlated  with  MMP-3  tissue  levels  (rs = 0.68,  p  < 0.05)  and
was  attenuated  with  selective  MMP-3  inhibitor.  Type  I collagen  formation  was  down-regulated  in  cul-
tured compared  with  native  skin  explants  but  was not  reduced  further  by  TNF-.  TNF-  had  no signiﬁcant
effect  on epidermal  apoptosis.  Our  data  indicate  that  TNF-  augments  collagenolytic  activity  of  MMP-1,
possibly  through  up-regulation  of MMP-3  leading  to gradual  loss  of  type  I  collagen  in human  skin.
thor© 2014  The  Au
ntroduction
Collagen is the major extracellular matrix (ECM) component
f skin and responsible for its structural integrity. Type I colla-
en accounts for about 75–80% of the collagen in normal human
kin (Lovell et al., 1987). Collagen homeostasis is maintained by
egradative and synthetic pathways. This balance can be disturbed
y intrinsic and extrinsic factors.
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BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
The pleiotropic cytokine tumor necrosis factor (TNF)- is
involved in many physiologic and pathologic processes in the skin
(Bashir et al., 2009). For example, ultraviolet radiation up-regulates
TNF- in keratinocytes and ﬁbroblasts that may contribute to the
photoaging processes of the dermal ECM (Bashir et al., 2009).
The mechanisms behind the direct effects on skin integrity of
elevated TNF- independent of its pro-inﬂammatory role are
poorly delineated.
Hypothetically, TNF- acts via induction of the matrix metal-
loproteinases (MMPs), a family of 23 human members that have
tissue-destructive potential (Nagase et al., 2006). The collagenases
MMP-1, MMP-8 and MMP-13 preferably cleave the native triple
helical region of collagen types I, II, III and V. The gelatinases MMP-
9 and MMP-2 preferentially degrade type IV collagen although
MMP-2 and its endogenous activator MMP-14 exhibit
access article under the CC BY-NC-ND license (http://creativecommons.org/
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ollagenolytic activity in vitro (Fields, 2013). Stromelysins (MMP-3
nd MMP-10) have broad substrate speciﬁcity but do not cleave
ative interstitial collagens.
The action of MMPs  in tissues is tightly regulated (Ra and Parks,
007). The activation of secreted latent MMPs  involves proteolytic
leavage of the propeptide domain by tissue or plasma proteinases
n a stepwise fashion (Suzuki et al., 1990). The organomercurial
-aminophenylmercuric acetate (APMA) is used to activate MMPs
n vitro. Once activated, another line of control of degradation is
xerted by tissue inhibitor of metalloproteinases (TIMPs), which
ind MMPs  with high afﬁnity (Brew and Nagase, 2010).
In monocellular systems, TNF- up-regulated MMP-1, MMP-3
nd MMP-9 (Han et al., 2002; Ravanti et al., 1999; Wong et al., 2001)
hat was accompanied by increased type I collagenolysis (Meikle
t al., 1989). In more complex skin organ cultures that account for
mportant ECM and mesenchymal-epithelial interactions (Tandara
nd Mustoe, 2011), TNF- was found to promote activation of
MP-2 via up-regulation of MMP-14 (Han et al., 2001). The same
roup reported up-regulation of MMP-3 and down-regulation of
IMP-1 with TNF- exposure (Han et al., 2002). No functional data
ere coupled to the MMP  and TIMP expression proﬁles or activa-
ion mechanisms.
Our primary aim was to study the effect of exogenous TNF-
n overall collagen degradation and speciﬁcally on type I col-
agen turnover in organ-cultured human skin explants. Second,
he origin of collagen degrading proteinases was studied using
he nonselective MMP  inhibitor GM6001. Further elucidation of
he collagenolytic processes was performed with TIMP-1, MMP-
 neutralizing antibody and selective MMP-3 inhibitor in a type
 collagenase assay. The expression of selected MMPs  and TIMPs
as also assessed. Finally, viability and apoptosis in cultured skin
xplants were examined using lactate dehydrogenase (LDH) and
erminal deoxynucleotidyl transferase-mediated dUTP nick end-
abeling (TUNEL) assays.
aterials and methods
eagents
Reagents as well as MMP-1 (M4696), MMP-3 (HPA007875) and
-actin (A5441) antibodies were purchased from Sigma-Aldrich
St. Louis, MO,  USA). Monoclonal MMP-1 antibody (MAB901),
gG1 (MAB002) and rhTIMP-1 were purchased from R&D Systems
Abingdon, UK). Active rhMMP-1 and rhMMP-3 were purchased
rom PeproTech (Rocky Hill, NJ, USA). MMP-2 was from Millipore
Billerica, MA,  USA). Type I collagen antibody (ab138492) was pur-
hased from Abcam (Cambridge, UK).
The IC50 for GM6001 is below 10 nM for the tested MMPs
Ågren et al., 2011). The IC50 for the selective MMP-3 inhibitor
K370106 (Tocris Bioscience, Bristol, UK) has been determined to
3 nM for MMP-3, 34 M for MMP-2, 1.75 M for MMP-8, 30 M
or MMP-9, 2.3 M for MMP-13 and 67 M for MMP-14. MMP-1
ctivity was reduced by 20% with 100 M UK370106 (Fray et al.,
003).
reparation, allocation to treatment groups, culture conditions
nd processing of skin explants
The study was approved by the local ethics committee. Healthy
emale Caucasian patients undergoing elective mammary or
bdominal reduction surgery under general anesthesia donated
kin after giving their written consent.
The fat-free skin in sterile saline at 4 ◦C was  used within 4 h
fter removal. From each donor, 115 skin explants were asep-
ically excised using an 8-mm trephine. Fifteen explants weref Cell Biology 94 (2015) 12–21 13
procured directly (native skin); 5 were ﬁxed in 4% phosphate-
buffered paraformaldehyde (PFA) for 24 h at 4 ◦C (from donors 1–4),
5 were snap frozen and stored at −80 ◦C, and 5 were subjected to
total hydroxyproline determination. The remaining 100 explants
were allocated randomly to 10 groups (10 explants per group) for
culture.
Explants were incubated without (control) or with rhTNF- at
10 ng/ml (Han et al., 2002, 2001) in the absence (0 M GM6001)
or presence of 0.01, 0.1, 1.0 and 10 M GM6001 submerged in
1.0 ml  keratinocyte growth medium (KGM)-2 (PromoCell, Heidel-
berg, Germany) in 24-well tissue culture plates (Nunc, Roskilde,
Denmark) at 37 ◦C in a humidiﬁed atmosphere of 5% CO2/air.
KGM-2, which contains 0.125 ng/ml epidermal growth factor,
5 g/ml insulin, 0.33 g/ml hydrocortisone, 10 g/ml transferrin,
0.39 g/ml epinephrine, 4 l/ml bovine pituitary extract, 6 mmol/l
glucose, 50 ng/ml amphotericin-B, 100 g/ml penicillin, 100 U/ml
streptomycin, was  supplemented with 1.4 mM CaCl2. The addition
of Ca2+ is necessary to maintain epidermal and dermal integrity
under serum-free culture conditions (Tavakkol et al., 1999). Cell-
culture tested dimethyl sulfoxide was present in all cultures at 0.1%
(v/v). Spent media were replaced after 2, 4 and 6 days of incubation
with fresh medium containing identical reagents to day 0. The con-
ditioned media from days 4 and 8 were centrifuged at 12,000 × g for
30 min  and stored at −80 ◦C until analyzed. Five of the cultured skin
explants were ﬁxed in PFA (from donors 1–4) and 5 were stored at
−80 ◦C until analyzed.
Normal human epidermal keratinocytes
Keratinocytes were isolated from 37-y-old male and maintained
according to Furukawa et al. (1987). The cells were incubated with-
out (control) or with TNF- in 3.0 ml  KGM-2 with 1.4 mM Ca2+ in
a 6-well tissue culture plate (Nunc). After 2 days of incubation,
conditioned media were aspirated and cells detached by 0.25%
trypsin/0.02% ethylenediaminetetraacetic acid (EDTA). The total
number of cells and viability were determined by automated cell
counter (CountessTM; Life Technologies, Carlsbad, CA, USA). Cells
were lysed in CNTZ buffer (10 mM cacodylate-HCl, pH 6.0, 1.0 M
NaCl, 0.01% (v/v) Triton X-100, 1 M ZnCl2 and 0.2 mg/ml NaN3).
LDH activity
This assay (Roche Diagnostics) was performed in 96-well plates
(Nunc). Conditioned media (100 l) and reaction mixture (100 l)
was incubated for 30 min  at ambient temperature protected from
light. Fifty microliters stop solution were added and the OD  read
at 492 nm and 690 nm in a microplate reader (Multiskan MCC/340;
Labsystems, Helsinki, Finland).
Collagen degradation
Fragmented collagen in the tissue and released into the media
was measured as hydroxyproline colorimetrically (Ågren et al.,
2006). The amount of degraded collagen was expressed as g of
hydroxyproline per explant.
Type I collagen degradation and biosynthesis
As an indicator of type I collagen degradation, C-terminal
telopeptide of type I collagen (ICTP) was measured by an enzyme
immunoassay kit (Orion Diagnostica, Espoo, Finland). De novo
synthesis of type I collagen was  measured by type I C-terminal
collagen propeptide (CICP) released into the conditioned medium
(MicroVue; Quidel Corporation, San Diego, CA, USA). Also, day-
4 media were centrifuged at 15,000 × g for 15 min  using 300 kDa
1 rnal of Cell Biology 94 (2015) 12–21
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Table 1
Demographics of the female donors and hydroxyproline content of skin.
Donor Age (years) Skin typea Location Hydroxyproline (g)b
1 38 II Breast 884 ± 80
2  49 I Breast 921 ± 55
3  19 IV Breast 787 ± 55
4  45 III Abdomen 1009 ± 81
5  66 II Abdomen 1171 ± 88
6  34 II Abdomen 1264 ± 114
10 mM CaCl2, 1 M ZnCl2 and 0.1% Triton X-100 with or with-
out GM6001 at 10 M.  Gels were stained with Colloidal Blue (Life
Technologies).
Fig. 1. Effect of TNF- on collagen degradation of cultured human skin explants
monitored by hydroxyproline-containing peptides released into the media after 84 M.S. Ågren et al. / European Jou
ut-off devices (Vivaspin 500; Sartorius, Epsom, UK) to isolate CICP
rom type I procollagen (Kopanska et al., 2013).
istology, MMP-1 immunohistochemistry and TUNEL
mmunohistoﬂuorescence
The ﬁxed tissues were embedded in parafﬁn. Serial 5-m sec-
ions were cut from each block. Morphology was assessed in
ematoxylin-eosin-stained sections.
MMP-1 immunohistochemistry was performed with the EnVi-
ion Flex+ (K8000; Dako, Glostrup, Denmark) polymer peroxidase
iaminobenzidine system (Skaland et al., 2010). Tissues were ﬁrst
ubjected to heat-induced epitope retrieval for 20 min  at 97 ◦C
sing Tris-EDTA solution pH 9.0 in the pre-treatment module
Dako). Subsequently, sections were incubated with the MMP-1
onoclonal antibody at 1:10 dilution (50 g/ml) for 2 h at ambient
emperature in the Dako Autostainer Link 48 and treated accord-
ng to the manufacturer’s protocol. Selected sections that were not
re-treated were incubated with the MMP-1 antibody for 18 h at
◦C. Adjacent sections were incubated with negative isotype con-
rol at the same concentration. Sections were counterstained with
ematoxylin and cover-slipped. Epidermal and stromal staining
ere scored separately by blinded senior pathologist (L. H. C.) on a
-tiered scale: 0, no; +, weak; ++, moderate; +++, intense staining.
TUNEL staining was carried out following pre-treatment with
roteinase-K (20 g/ml) using the ApopTag® ﬂuorescein in situ kit
Millipore). Images were captured using a ﬂuorescence microscope
Eclipse Ti-U, Nikon, Amsterdam, Netherlands) equipped with a
igital camera (DS-Qi1Mc, Nikon).
issue extraction
Tissues extracts were prepared for 18 h at 4 ◦C using CNTZ
uffer (20 l/mg tissue) optimized for collagenase extraction
Mirastschijski et al., 2002) and supplemented with EDTA-free
roteinase inhibitor cocktail/1 M pepstatin (Roche Diagnostics,
annheim, Germany). Tissue extracts were kept at −80 ◦C until
nalyzed.
ype I collagenolytic activity assay
Enzymes were incubated with 0.25 g/ml type I collagen from
ovine skin (Millipore) with or without inhibitors/APMA as indi-
ated in a total volume of 40 l with 25 M ZnCl2, and 1 mM CaCl2
n the presence of the proteinase inhibitor cocktail and pepstatin
t 24 ◦C for 240 h unless stated otherwise. Samples were elec-
rophoresed on NuPAGE® 4–12% Bis-Tris gels (Life Technologies)
nder reducing conditions and gels stained with Colloidal Blue
Salsas-Escat et al., 2010). Gels were scanned and the extent of
ollagen digestion was calculated from the density of the 1, 2,
/41 and 3/42 bands (Welgus et al., 1981) determined by ImageJ
National Institutes of Health, Bethesda, MD,  USA) and expressed
n percentage (%).
MP  and TIMP analyses
MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-10, MMP-13,
IMP-1, TIMP-2 and TIMP-4 were measured using Quantibody®
uman MMP/TIMP array (RayBiotech, Norcross, GA, USA). MMP-
 and MMP-3 were quantiﬁed by ELISA kits (Boster Biological
echnology, Fremont, CA, USA). MMP-2 contents were estimated
y gelatin zymography (Mirastschijski et al., 2002) relative to
MP-2 standard run in parallel using densitometry (ImageJ). TIMP-
 was assayed by ELISA kit from PeproTech (Henriksen et al.,
013).a Determined according to Fitzpatrick (1988).
b Mean ± SEM of 5 separate 8-mm skin explants before culturing.
Western blot analyses
Samples were electrophoresed using 10% sodium dodecyl
sulfate-polyacrylamide gels under reducing conditions and elec-
trotransferred onto polyvinylidene ﬂuoride (PVDF) membrane
(Immobilon® FL, Millipore) or nitrocellulose (Bio-Rad). The mem-
branes were blocked with Odyssey buffer (Li-Cor, Lincoln, NE,
USA) and incubated for 18 h at 4 ◦C with primary antibodies
against MMP-1 diluted 1:500, MMP-3 diluted 1:250, type I colla-
gen diluted 1:1,000 (nitrocellulose) and -actin diluted 1:70,000
(nitrocellulose). The membranes were incubated with matching
IRDye®-conjugated secondary antibodies for 1 h at ambient tem-
perature and immunoreactions visualized by infrared imaging
(Li-Cor).
ˇ-Casein zymography
Samples were separated by 12% sodium dodecyl sulfate-
polyacrylamide gels copolymerized with 0.5 mg/ml  bovine -
casein at constant 125 V under nonreducing conditions at 4 ◦C for
3 h. Gels were renatured in 2.5% Triton X-100 for 30 min  and incu-
bated for 140 h at 37 ◦C in 50 mM Tris–HCl (pH 7.5) containingdays  in culture. The accumulated amount of hydroxyproline from 10 separate organ-
cultured 8-mm explants of each of the 6 donors and group (control and TNF-)
was used for the global calculations. Mean ± SEM (n = 6). (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web  version of
this article.)
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Fig. 2. Effect of TNF- and GM6001 on type I collagen turnover assessed by the bio-
chemical markers of degradation ICTP (A), neosynthesis CICP (B) and type I collagen
formation (C and D). (A and B) Media from ﬁve explants per donor were pooled
and then analyzed. CICP levels after ultraﬁltration of day-4 samples are indicated by
lower bars (B). Mean ± SEM. ** p < 0.01, *** p < 0.005 versus control at respective time
point. (C and D) Western blot analysis for the 1 chain of type I collagen and -actin
of  pooled concentrated (Amicon® Ultra; Millipore) CNTZ tissue extracts (C and D)
and  conditioned media (C) from 30 individual 8-mm skin explants (5 explants from
each  of the 6 donors). (C) Loading of tissue extracts was normalized to the -actin
content determined separately (D) and media were adjusted to the corresponding
volume to biopsy weight ratio. Lane 1, native skin; 2, control; 3, GM6001 (10 M);
4,  TNF-. (D) Equal volume (12.5 l) of the tissue extracts was applied to each well.
Fig. 3. LDH activity in media from cultured skin explants (A), and in cell lysates
of  and media from normal human epidermal keratinocytes (B). (A) Individual sam-
ples,  each comprising the combined media from 5 separate 8-mm skin explants,
were analyzed. n = number of skin donors. (B) Conﬂuent keratinocytes of the second
passage were treated with or without TNF- for 2 days. Mean ± SEM. * p < 0.05, **
p < 0.01, *** p < 0.005 versus control.
Statistical analyses
Wilcoxon matched pairs and Spearman rank correlation tests
were applied (FigSys, version 2.4.3; Biosoft, Cambridge, UK).
p < 0.05 was  considered statistically signiﬁcant. Numerical data are
presented as mean ± SEM. n = number of skin donors.
Results
To elucidate the inﬂuence and mechanisms of TNF- on colla-
gen degradation in skin we  cultured skin explants ex vivo from six
healthy females for 8 days (Table 1).
Collagen degradation
We ﬁrst established the time-dependence on collagen degrada-
tion in the skin explants by measuring the release of hydroxyproline
into the culture medium. From the initiation of culture to day 4 a
total of 1.4 ± 0.4 (n = 6) g hydroxyproline was released. Then a pro-
found increase (p < 0.005) in hydroxyproline liberation occurred to
day 8 amounting to 19.8 ± 10.6 (n = 6) g. Addition of TNF- to the
medium resulted in 1.8 ± 0.5 (n = 6) g hydroxyproline release over
days 0–4 and 38.7 ± 11.3 (n = 6) g over days 4–8. Overall, TNF-
treatment increased the cumulative hydroxyproline in the medium
over 8 days (40.5 ± 11.7 g) in all six donors (p < 0.005) compared
with control (21.2 ± 11.0 g) treatment (Fig. 1).
The nonselective MMP  inhibitor GM6001 was  added at
0.01–10 M to the skin cultures. GM6001 reduced total hydroxy-
proline release from control skin explants at 1 M to 3.6 ± 0.6 g
(p < 0.01) and at 10 M to 1.7 ± 0.2 g (p < 0.005), and from
TNF--treated explants at 0.1 M to 18.4 ± 4.5 g (p < 0.005), at
16 M.S. Ågren et al. / European Journal of Cell Biology 94 (2015) 12–21
Fig. 4. Apoptosis assessed by TUNEL immunohistoﬂuorescence. (A) Digoxigenin-labeled 3′-OH DNA termini were detected by sheep polyclonal anti-digoxigenin antibody
conjugated with ﬂuorescein (red). Slides were mounted using medium containing 4′ ,6-diamidino-2-phenylindole (green). Representative sections of native (left), control-
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pidermal area in mm2, determined in two sections from two explants from each do
or  the global calculations. Mean ± SEM (n = 4). (For interpretation of the references
 M to 4.7 ± 0.8 g (p < 0.005) and at 10 M to 1.8 ± 0.3 g
p < 0.005).
ype I collagen turnover
To speciﬁcally address type I collagen turnover, biomarkers for
egradation (ICTP) and neosynthesis (CICP) were analyzed in con-
itioned media.
ICTP levels correlated strongly with those of hydroxyproline
n control-treated skin explants (rs = 0.82, p < 0.005, n = 12). TNF-
reatment increased (p < 0.01) the ICTP levels compared with con-
rol while ICTP levels were reduced (p < 0.005) with 10 M GM6001
n day 8 (Fig. 2A).
CICP levels showed a reverse time course compared with ICTP
nd decreased (p < 0.005) from day 4 to day 8. In the day-8 samples,
ICP levels were statistically unchanged with TNF- treatment but
ere reduced (p < 0.005) with 10 M GM6001. Elimination of type
 procollagen by ultraﬁltration reduced the CICP levels similarly
n the three groups (∼30%) on day 4 (Fig. 2B). Because CICP lev-
ls in medium are indirect markers of type I collagen deposition
e carried out Western blotting analysis for type I collagen (1
hain) monomers in tissue extracts of skin explants (Fig. 2C). The
issue-derived type I collagen was reduced appreciably in cultured
ompared with noncultured skin. TNF- increased while GM6001
reatment slightly reduced type I collagen levels when normalized
o the amount of -actin (Fig. 2C and D). Type I collagen was not
etected in conditioned media (Fig. 2C).
DH, morphology and apoptosisThe LDH activity in media of control skin cultures decreased
p < 0.005) from day 4 to day 8. LDH was higher with GM6001
10 M)  treatment on day 8 and with TNF- days 4 and 8 comparedd by dashed line. Scale bars: 500 m.  (B) Total number of TUNEL-positive cells per
y two blinded investigators by image analysis (NIS-Elements AR, Nikon), were used
or in this ﬁgure legend, the reader is referred to the web version of this article.)
with control (Fig. 3A). In normal human epidermal keratinocytes,
TNF- treatment increased cellular LDH (Fig. 3B). The total number
of cells after 2 days treatment was 4.9 ± 0.4 × 105 in control wells
and 5.0 ± 0.8 × 105 in TNF- wells. The corresponding viabilities
were 97.0 ± 0.6% and 96.0 ± 0.6%.
Morphologically, no discernible dermal changes occurred with
culturing of the skin explants for 8 days possibly with the excep-
tion of slightly decreased number of cells compared with native
skin. Epidermis had partially separated from dermis with ensuing
pyknosis in cultured as opposed to noncultured skin. The degree of
epidermal detachment was  extensive in the control (40–50% of the
length) and TNF- (30–40%) groups but suppressed with GM6001
(0–20%) treatment. Apoptosis, assessed by TUNEL immunoﬂuores-
cence, was prominent in epidermis and sparse in dermis of cultured
skin explants compared with native skin (Fig. 4A). There was no sig-
niﬁcant difference in epidermal apoptosis between the control and
TNF- groups (Fig. 4B).
Type I collagenolysis
We  next assessed the collagenolytic activity using exogenous
native type I skin collagen. Pooled tissue extracts of TNF--treated
skin explants possessed increased collagenolytic activity (34%)
compared with control-treated (19%) skin explants. The difference
in collagenolytic activity between TNF- and control-treated skin
was more pronounced with the MMP-activator APMA during the
assay. The collagenolytic activity of tissue extracts did not decline
appreciably with length of incubation. No collagenolytic activity
was detected in native skin (Fig. 5A). The MMP  inhibitors GM6001
and TIMP-1 blocked collagenolysis. Moreover, a monoclonal neu-
tralizing antibody against hMMP-1 abolished the collagenolytic
activity of tissue extracts of incubated skin explants from the two
groups (Fig. 5B). The MMP-1 antibody (10 g/ml) also completely
M.S. Ågren et al. / European Journal of Cell Biology 94 (2015) 12–21 17
Fig. 5. Digestion of native type I collagen by tissue-derived proteinases of native human skin (A), control (A and B) and TNF--treated human skin (A–C), active rhMMP-1
(D–F)  or trypsin (F). (A–C) Tissue extract pools from 30 individual 8-mm skin explants (5 explants from each of the 6 donors) per group were concentrated 3× (Amicon® Ultra;
Millipore). S, substrate. (B–D) Enzymes were incubated for 2 h with inhibitors before the substrate was added. (D) rhMMP-1 was incubated with substrate in the absence or
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cellularly in the stroma compared with native skin. There were
no apparent differences in localization or intensity of the MMP-1
Fig. 6. MMP  and TIMP contents of native skin and cultured skin explants treatedresence of UK370106. (A–D, F) Collagenolytic activity in percentage of type I colla
unction  of concentration and time of incubation (inset, 1 ng/ml). (F) Trypsin (Wor
as  carried out at identical assay conditions. rhMMP-1, 2.5 ng/ml. *, position of tryp
brogated the collagenolytic activity (85%) of control day-8 pooled
edia from donor 1. Selective MMP-3 inhibition with UK370106
educed type I collagenolysis by about 60% in the presence of
PMA but less in the absence of APMA. UK370106 at 1 M did not
ecrease the collagenolytic activity of rhMMP-1 (Fig. 5B–D). The
ssay was linear to about 30% collagenolysis (Fig. 5E). The type I col-
agen substrate was resistant to trypsin while denatured substrate
as completely digested. rhMMP-1 generated the anticipated 3/4
nd 1/4 fragments of the 1(I) and 2(I) chains (Fig. 5F).
MP  proﬁling of native and cultured skin explants
Collectively, MMPs  were responsible for the degradation of
ndogenous and exogenous type I skin collagen. Our initial
pproach for identifying the operative MMPs  was  to analyze pooled
issue extracts using a quantitative MMP/TIMP multiarray (Fig. 6).
learly, MMP-1 was the dominant MMP  in cultured skin explants.
MP-3 was barely detectable in quiescent skin but increased after
 days of culture. MMP-2 content of native skin was  ∼30 ng and
ncreased further in culture. The amount of MMP-8 in native skin
as ∼0.1 ng but was reduced after culture. The MMP-9 content
as likewise lowered after incubation. Although MMP-10 was
etectable in native and incubated skin the levels were insignif-
cant (<0.05 ng/explant). Tissue MMP-13 was nondetectable. The
IMP-1 content of the explants increased after culture whereas
IMP-2 decreased. TIMP-4 was nondetectable in the tissue. From
his screening we conclude that MMP-1, MMP-3, MMP-2 and TIMP-
 were the most prominent MMPs/TIMPs in our system and were
nalyzed on individual samples.ffect of TNF-  ˛ on MMP-1, MMP-3, MMP-2 and TIMP-1
There was no difference in total tissue MMP-1 contents between
he TNF- and control groups determined by the ELISA assay.egradation is shown below each lane. (E) Effect of rhMMP-1 on collagenolysis as a
on, Lakewood, NJ, USA) treatment of native or denatured (56 ◦C, 30 min) substrate
, denatured.
On the other hand, MMP-1 content in media was increased with
TNF- present during incubation (Fig. 7A). Western blot analy-
sis indicated that MMP-1 was  in catalytically active glycosylated
and nonglycosylated forms in the tissue while both latent and
active MMP-1 glycosylated and nonglycosylated forms were found
in about equal proportions in the media (Fig. 7B). Immunohis-
tological staining of cultured skin explants clearly showed that
MMP-1 was increased throughout the epidermis, being almostwithout (control) or with TNF- (10 ng/ml) were measured in pooled tissue extracts
by  the Quantibody® array and expressed in total amount (ng) per explant. Each pool
comprised extracts made from 30 individual 8-mm skin explants (5 explants from
each  of the 6 donors per group). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 7. MMP-1 and MMP-3 expression in control and TNF--treated skin analyzed by ELISA (A and D), Western blot (B and E) and -casein zymography (F), and MMP-1
immunohistochemistry (C) and MMP-3 correlation to ICTP (G) after 8 days of incubation. (A and D) Pooled tissue extracts and media from ﬁve explants per donor and group
were  assayed. Mean ± SEM. ** p < 0.01, *** p < 0.005 versus control. n = number of skin donors. (B and E) The PVDF membrane was ﬁrst probed with the polyclonal MMP-1
antibody  (B), then stripped and reprobed with the polyclonal MMP-3 antibody (E). Lanes 1 and 3, control; 2 and 4, TNF-; 1 and 2, pooled tissue extract (18 l/lane) from 30
individual 8-mm skin explants from the 6 donors (1–6) per group; lanes 3 and 4, pooled media (18 l/lane) from 24 individual 8-mm skin explants from 5 donors (media from
donor  1 was  lost) per group. Std.: 42.7 kDa rhMMP-1 (14 ng). Glycosylated and nonglycosylated latent and active MMP-1/MMP-3 doublets are indicated. (C) Representative
sections of native (a, d and g), or cultured skin explants from control (b, e and h) and TNF- groups (c, f and i) treated with primary monoclonal MMP-1 antibody that
detects  latent and active forms (a–f) or with isotype (negative) control (g–i). (a–c, 40×;  d–i, 900×). (F) Casein gels were incubated in the absence (Buffer) or presence of
10  M GM6001. Lane 1, rhMMP-3 (5 ng); 2, pooled media from control-treated explants (15 l); 3, pooled media from TNF--treated explants (15 l); 4, rhMMP-1 (2 ng).
Mark12TM (Life Technologies) molecular weight marker was run in parallel lane. Upper doublets represent latent forms of MMP-3 (upper bands) and MMP-1 (lower bands)
and  lower doublets active forms of MMP-3 (upper bands) and MMP-1 (lower bands). (G) Tissue MMP-3 contents and corresponding ICTP in media. Each symbol as indicated
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(n  Fig. 1 represents pooled tissue extracts and media from ﬁve explants per donor.
For  interpretation of the references to color in this ﬁgure legend, the reader is refe
mmunoreactivity between control and TNF--treated skin
xplants. Native skin showed predominance of MMP-1 extra-
ellularly in the stroma (++), most intensely in the papillary
ermis, and in the nucleus (++) of scattered keratinocytes
n epidermis (Fig. 7C). Nuclear MMP-1 was also observed in
ections without pre-treatment for antigen retrieval although
he signal was weaker than with pre-treatment. In contrast,
MP-1 was entirely cytoplasmic in human oral epithelium
Supplementary Fig. S1).NF--treated skin explants of donor 1 is missing due to lost pooled media sample.
 the web  version of this article.)
MMP-3 contents in tissue as well as in media were raised in
the TNF- group compared with the control group measured by
ELISA (Fig. 7D). Most of the increased MMP-3 with TNF- was
attributed to increased active MMP-3 species. The faint bands in
lanes 3 and 4 below latent and active MMP-3 bands are signal
from residual bound MMP-1 antibody due to incomplete stripping
(Fig. 7E). Increased catalytic activity of MMP-3 in the TNF- group
was demonstrated by -casein zymographic analysis. GM6001 at
10 M completely abrogated the appearance of all caseinolytic
M.S. Ågren et al. / European Journal o
Fig. 8. MMP-2 (A and B) and TIMP-1 (C) tissue levels. (A) Total and active (lower bars)
MMP-2 contents estimated by gelatin zymography. (B) In the zymogram, MMP-2
standard and pooled tissue extracts (1.0 l) from 30 individual 8-mm skin explants
per group were loaded into each lane. Lane 1, rhMMP-2 (50 pg; PF037); 2, native
skin; 3, control; 4, TNF-. (C) TIMP-1 levels determined by ELISA. (A and C) Pooled
tissue extracts from ﬁve separate native or organ-cultured 8-mm skin explants from
each of the donors and group were used for the analyses. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of
t
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whis  article.) Mean ± SEM (n = 6).
ands (Fig. 7F). MMP-3 tissue contents correlated with type I
ollagen degradation measured as ICTP released into the media
Fig. 7G).
MMP-2 tissue levels were semiquantiﬁed by gelatin zymogra-
hy (Fig. 8A and B). No signiﬁcant effects of TNF- treatment on
ither total or active MMP-2 were observed.
Tissue TIMP-1 quantities did not differ between TNF--treated
nd control-treated skin although they were increased compared
ith native skin (Fig. 8C).f Cell Biology 94 (2015) 12–21 19
Discussion
TNF- is a multifunctional cytokine with profound effects
on the skin (Bashir et al., 2009). In the present study, TNF-
accelerated collagen degradation in cultured human skin explants.
This was  achieved independently of the secondary effects of TNF-
on inﬂammation observed in vivo.
Collagen breakdown was  measured indirectly by released
hydroxproline-containing peptides into the culture medium. In a
similar experimental set-up to ours, Koob et al. (1980) found that
collagen degradation paralleled de novo protein synthesis. Because
insoluble type I collagen is the major dermal component (Lovell
et al., 1987), its degradation was  speciﬁcally measured by soluble
ICTP fragments. ICTP correlated with hydroxyproline suggesting
that type I collagen was  the main endogenous substrate in our
organ-culture system. Furthermore, we  could conﬁrm that ICTP is
a robust biomarker of tissue MMP  activity (Garnero et al., 2003).
Although hydroxyproline and ICTP release was MMP  driven
we can only speculate on the speciﬁc MMPs  inﬂuenced by TNF-
. Native type I collagen is cleaved into 3/4 and 1/4 fragments
by the classical collagenases MMP-1, MMP-8 and MMP-13. Expec-
tedly, MMP-8 and MMP-13 tissue levels were negligible compared
with MMP-1 (Tandara and Mustoe, 2011). Moreover, tissue-derived
proteolytic enzymes from cultured skin explants cleaved native
type I collagen molecules into 3/4 and 1/4 fragments. This col-
lagenolytic activity was blocked by a neutralizing MMP-1 antibody.
TNF- treatment increased the amount of released MMP-1 but
not the MMP-1 bound to the tissue due to lack of binding of the
proform of MMP-1 to collagen (Murphy et al., 1992). Consider-
ably less of active rhMMP-1 than the MMP-1 quantity present
in the tissue was required to degrade the corresponding amount
of type I collagen. This discrepancy was most likely due to the
presence of the endogenous TIMP inhibitors in tissue extracts.
Importantly, TNF- did not signiﬁcantly inﬂuence TIMP-1 tissue
content. Taken together, these ﬁndings strongly suggest that MMP-
1 was  activated indirectly by TNF- causing the increased type I
collagenolysis.
MMP-1 activation processes are multiple and complex (Ra and
Parks, 2007). MMP-3 is coordinately synthesized with MMP-1 and
is induced by TNF- in whole human skin (Han et al., 2002; Wong
et al., 2001). MMP-3 has the capacity to render full collagenolytic
activity to MMP-1 (Suzuki et al., 1990). Here, the involvement of
MMP-3 in type I collagenolysis was indicated by the signiﬁcant cor-
relation with ICTP levels. Up-regulation of MMP-3 by TNF- may
thus account for excessive collagen degradation through its unique
capacity to fully activate MMP-1 by cleavage of the Gln80-Phe81
bond (Suzuki et al., 1990). These subtle conformational changes
of MMP-1 could not be detected by Western blot analysis but we
were able to attenuate tissue-associated MMP-1 activation using a
selective MMP-3 inhibitor.
In periosteal rabbit connective tissue, MMP-2 and not MMP-
1 accounted for collagen breakdown (Kerkvliet et al., 1999). This
deviation from our results may  be explained by the lack of epithe-
lium in their tissue. In our culture system, epidermis was the major
source of MMP-1. Differences in collagenolytic activity was not
attributed to MMP-2 (Crabbe et al., 1994) because the levels of
active MMP-2 did not differ signiﬁcantly between the two groups.
For the same reason, the MMP-2 activator MMP-14 was unlikely
regulated by TNF- in our experiments. Furthermore, type I col-
lagenolysis was  efﬁciently blocked by TIMP-1 which is an extremely
poor inhibitor of MMP-14 (Sabeh et al., 2009). Collectively, nei-
ther MMP-2 nor MMP-14 seemed to contribute signiﬁcantly to
the TNF--mediated degradation of type I collagen in human
skin.
Formation of type I collagen requires processing of C-
propeptides and N-propeptides of procollagen by zinc-dependent
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ndopeptidases, e.g. BMP-1 and ADAMTS-2 in skin (Canty and
adler, 2005). Surprisingly, similar hydroxamate-based com-
ounds to GM6001 are poor inhibitors of procollagen C-proteinase
Ovens et al., 2000). Thus, the observed inhibited release of the
ICP could be attributed to slight cytotoxicity of GM6001 that
as manifested by increased LDH release. Although there was a
rend of increased type I collagen deposition with TNF- this was
ot reﬂected in elevated CICP levels possibly due to increased N-
roteinase activity by TNF- (Harrison et al., 2006).
An incidental ﬁnding was the distinct and speciﬁc nuclear pref-
rence of MMP-1 in keratinocytes in quiescent skin. We  could
nd only one publication reporting nuclear MMP-1 and this was
n breast carcinoma cells (Boström et al., 2011). MMP-1 has
lso been ascribed an anti-apoptotic effect (Limb et al., 2005).
otably, in human oral epithelium MMP-1 was located in the
ytosol.
The increased LDH in media with TNF- treatment without
oncomitant increased epidermal apoptosis is a conundrum and
ifﬁcult to explain. Our studies on primary human epidermal kera-
inocytes indicate that TNF- increased LDH activity per se rather
han causing membrane damage. This could explain the increased
DH release from the cultured skin explants. TNF- did not induce
pidermal apoptosis in agreement with earlier ﬁndings for primary
eratinocytes (Zimmermann et al., 2011). Moreover, we observed
 general decline in viability and gradual separation of epider-
is  from dermis over the 8-day culture period, which are known
henomena of organ-cultured skin (Kleszczyski and Fischer, 2012).
hese processes may  have increased the release of intracellular
athepsins which possess collagenolytic activity (Wagenaar-Miller
t al., 2007). Because the collagenolytic activity of the condi-
ioned media could be blocked by the neutralizing MMP-1 antibody
athepsins did not appear to play a signiﬁcant role in collagen
egradation. Epidermolysis was reduced with GM6001 indicating
ome involvement of MMPs  in this process as indicated in another
tudy (Mol  et al., 2009).
In summary, TNF- promoted collagen degradation in cultured
uman skin via the collagenolytic MMP-1 and MMP-3 axis. This
odel of dermal degeneration due to MMP  interactions with inter-
titial collagens may  be implicated for down-stream effects of other
xternal stimuli such as ultraviolet radiation.
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